Suttle AB - Search Results

1

Ranitidine does not alter adinazolam pharmacokinetics or pharmacodynamics.

Suttle AB, Songer SS, Dukes GE, Hak LJ, Koruda M, Fleishaker JC, Brouwer KL. Suttle AB, et al. J Clin Psychopharmacol. 1992 Aug;12(4):282-7. J Clin Psychopharmacol. 1992. PMID: 1527233 Clinical Trial.

2

Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat.

Suttle AB, Brouwer KL. Suttle AB, et al. Drug Metab Dispos. 1994 Mar-Apr;22(2):224-32. Drug Metab Dispos. 1994. PMID: 8013278

3

Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles.

Suttle AB, Pollack GM, Brouwer KL. Suttle AB, et al. Pharm Res. 1992 Mar;9(3):350-6. doi: 10.1023/a:1015890918883. Pharm Res. 1992. PMID: 1614968

4

Regional gastrointestinal absorption of ranitidine in the rat.

Suttle AB, Brouwer KL. Suttle AB, et al. Pharm Res. 1995 Sep;12(9):1311-5. doi: 10.1023/a:1016269522828. Pharm Res. 1995. PMID: 8570527

5

Gastrointestinal transit and distribution of ranitidine in the rat.

Suttle AB, Brouwer KL. Suttle AB, et al. Pharm Res. 1995 Sep;12(9):1316-22. doi: 10.1023/a:1016221606898. Pharm Res. 1995. PMID: 8570528

6

Comparison of zafirlukast (Accolate) absorption after oral and colonic administration in humans.

Fischer JD, Song MH, Suttle AB, Heizer WD, Burns CB, Vargo DL, Brouwer KL. Fischer JD, et al. Among authors: suttle ab. Pharm Res. 2000 Feb;17(2):154-9. doi: 10.1023/a:1007509112383. Pharm Res. 2000. PMID: 10751029 Clinical Trial.

7

Phase I trial of pazopanib in patients with advanced cancer.

Hurwitz HI, Dowlati A, Saini S, Savage S, Suttle AB, Gibson DM, Hodge JP, Merkle EM, Pandite L. Hurwitz HI, et al. Among authors: suttle ab. Clin Cancer Res. 2009 Jun 15;15(12):4220-7. doi: 10.1158/1078-0432.CCR-08-2740. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509175 Clinical Trial.

8

Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamics.

Yau T, Chen PJ, Chan P, Curtis CM, Murphy PS, Suttle AB, Gauvin J, Hodge JP, Dar MM, Poon RT. Yau T, et al. Among authors: suttle ab. Clin Cancer Res. 2011 Nov 1;17(21):6914-23. doi: 10.1158/1078-0432.CCR-11-0793. Epub 2011 Aug 10. Clin Cancer Res. 2011. PMID: 21831954 Clinical Trial.

9

Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study.

Shibata SI, Chung V, Synold TW, Longmate JA, Suttle AB, Ottesen LH, Lenz HJ, Kummar S, Harvey RD, Hamilton AL, O'Neil BH, Sarantopoulos J, LoRusso P, Rudek MA, Dowlati A, Mulkerin DL, Belani CP, Gandhi L, Lau SC, Ivy SP, Newman EM. Shibata SI, et al. Among authors: suttle ab. Clin Cancer Res. 2013 Jul 1;19(13):3631-9. doi: 10.1158/1078-0432.CCR-12-3214. Epub 2013 May 7. Clin Cancer Res. 2013. PMID: 23653147 Free PMC article. Clinical Trial.

10

Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumors.

Tan AR, Dowlati A, Jones SF, Infante JR, Nishioka J, Fang L, Hodge JP, Gainer SD, Arumugham T, Suttle AB, Dar MM, Lager JJ, Burris HA 3rd. Tan AR, et al. Among authors: suttle ab. Oncologist. 2010;15(12):1253-61. doi: 10.1634/theoncologist.2010-0095. Epub 2010 Dec 8. Oncologist. 2010. PMID: 21147873 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters